Should I take HRT? The decision, laid out honestly

HRT replaces the estrogen your ovaries stop making through the transition, usually with progesterone alongside it if you have a uterus. That is the whole mechanism. Everything it helps with follows from what estrogen was quietly doing before.

The strongest evidence is for hot flashes and night sweats, where it is the most effective treatment known. Sleep broken by night sweats tends to improve with them. Genitourinary symptoms, meaning vaginal dryness and urinary changes, respond well to local vaginal estrogen, which works at any age and carries almost none of the systemic questions.

The evidence is real but more mixed for mood and joint aches, and thinner for brain fog on its own. A clinician who promises HRT will fix everything is overselling it. One who refuses to discuss it is underselling it. Both happen a lot.

Most of the reassuring modern evidence applies to women who start HRT under 60, or within ten years of their last period. Inside that window, for most healthy women, the balance of benefit and risk is generally favorable. That is the position of The Menopause Society in the US, and of the menopause societies on both sides of the Atlantic.

Starting later is not forbidden, and this matters if you are 58 and only now connecting your last decade to menopause. It means the conversation is more individual: your heart health, your bone picture, what you are treating and why. Some benefits, particularly for bones, remain. The certainty is simply lower, so the quality of the clinician matters more.

There is no rule that says you must stop at any particular age. Current guidance supports continuing for as long as the benefits hold up for you, reviewed properly each year.

The fear around HRT traces back to one 2002 study, the Women's Health Initiative, which was reported as a cancer alarm and emptied prescriptions worldwide within months. Twenty years of reanalysis have softened that picture considerably, and the study itself mostly looked at older women on older forms of the hormones.

The honest modern summary looks like this. Estrogen taken through the skin, as a patch, gel or spray, is not associated with the blood clot risk that tablets carry. Combined HRT is associated with a small increase in breast cancer risk with long use. For scale, the increase is of a similar order to the risk associated with drinking a couple of glasses of wine a night, and smaller than the risk associated with carrying significant extra weight.

Small is not zero, and your own history can change the picture entirely. A personal history of breast cancer, clotting disease or liver disease moves this from a general conversation to a specialist one. That is exactly what the appointment is for.

In the US, what you pay depends almost entirely on your plan. Insurance coverage for menopause care is patchy: many women pay only a copay for the visit and the prescription, and some plans decline menopause care outright. It is worth calling your insurer before you book, and asking what is covered rather than assuming. Cash-pay telehealth services built around menopause typically charge somewhere between $50 and $150 a month including clinician access.

The other US cost is finding someone trained. Plenty of primary care doctors had very little menopause teaching, so the first appointment can be the expensive one in time rather than money. In the UK, an NHS prepayment certificate covers a year of HRT for around £20 and the appointment is free, while private consultations typically run £150 to £300.

None of these numbers is trivial. Worth weighing against them: how long this has already been going on, and what another few years of it would cost you.